Building a Multi-Peptide Serum: Stacking Signal, Neurotransmitter and Carrier Peptides
A multi-peptide serum is only coherent if each active sits in a different mechanistic lane. How to assemble a signal, neurotransmitter and carrier peptide into one formula — the claim-arm logic, the order of addition, and the one incompatibility that decides the whole build.
Published June 3, 2026 · 8 min read · By Pepoderma Regulatory Team
The phrase "multi-peptide serum" sells, but a serum that carries three peptides from the same mechanistic family is not multi-peptide in any useful sense — it is one claim arm, tripled. A genuinely multi-peptide formula carries actives from different mechanistic lanes, so each one supports a distinct part of the story and none is redundant. This guide is the assembly manual: how to pick a signal peptide, a neurotransmitter peptide, and a carrier peptide that complement rather than overlap, the order to add them, and the single incompatibility that tends to decide the whole build.
How do you combine multiple peptides in one serum?
Combine across mechanistic lanes, not within one. Pick a signal peptide (a matrikine such as Matrixyl, studied as a proposed signal to support collagen and matrix), a neurotransmitter peptide (Argireline, SNAP-8, or SYN-AKE, studied around the appearance of expression lines), and a carrier peptide (GHK-Cu, studied around copper-delivered repair and renewal). Because the three lanes act through different proposed mechanisms, they combine rather than compete — three complementary claim arms in one formula. The build then comes down to a shared pH window, the order of addition, and keeping the copper-carrier phase chelator-free.
The four mechanistic lanes
Our four-types-of-peptides primer is the full map; in brief, cosmetic peptides fall into four functional families, and a multi-peptide serum is built by choosing across them:
| Lane | What it is studied to support | Example actives (INCI) |
|---|---|---|
| Signal (matrikine) | Proposed signal to build collagen / matrix | Matrixyl (Palmitoyl Pentapeptide-4), Hexapeptide-9 |
| Neurotransmitter | Appearance of dynamic expression lines | Argireline (Acetyl Hexapeptide-8), SNAP-8 (Acetyl Octapeptide-3), SYN-AKE |
| Carrier | Trace-element (copper) delivery → repair / renewal | GHK-Cu (Copper Tripeptide-1) |
| Enzyme-inhibitor | Slows matrix-degrading or pigment enzymes | various tetra-/oligopeptides |
A coherent three-arm serum usually draws one from the first three lanes. A fourth (an enzyme-inhibitor or a brightening MC1-R peptide) can be added if the claim set justifies it.
A worked three-arm build
Take a representative anti-aging serum brief — firmness, softer expression lines, a repair narrative — and assign one active per arm:
- Signal arm: a Matrixyl-family matrikine for the collagen-support story. (If a palmitoyl tail is unwelcome, the water-soluble matrikine Hexapeptide-9 plays the same lane without the oil-phase step.)
- Neurotransmitter arm: Argireline or SNAP-8 for the expression-line appearance — or both a presynaptic and a postsynaptic active (Argireline plus SYN-AKE) for the multi-pathway expression-line story.
- Carrier arm: GHK-Cu for the copper-delivered repair narrative — the active that sets the constraints for the whole formula.
Three arms, three different proposed mechanisms, one serum. The claim reads as "designed to support firmness, the appearance of expression lines, and skin renewal," each phrase mapping to a real, distinct active.
The one incompatibility that decides the build
If the serum contains GHK-Cu, the copper coordination governs everything else. The carrier has to stay chelator-free (no EDTA, which would strip the copper off the peptide), copper-clean, away from cationic bases, and clear of high-load reductive antioxidants (ascorbate, sulfite preservatives) in the same phase. That single requirement constrains the preservative system, the chelator choice, and the other actives more than anything else in the formula. The decision tree is simple:
- Keep the copper carrier → build the whole formula chelator-free and copper-clean, and route any incompatible co-active (high ascorbate, a cationic emulsifier) out of the shared phase.
- The carrier has to live in a copper-hostile base → swap GHK-Cu for the free peptide GHK, which drops the coordination constraints, and accept the loss of the copper-specific narrative and the blue.
Get that decision right first and the rest of the stack falls into place.
Order of addition
Once the carrier question is settled, the assembly order is conventional:
- **Build the water phase** on copper-clean process water with the buffer that holds the shared pH window (target 5.5–6.5, broadly tolerable across signal, neurotransmitter, and carrier peptides).
- **Pre-disperse the lipidated actives** (the Matrixyl-family matrikines, any palmitoyl signal peptide) in a small polysorbate or polyglyceryl co-solvent slurry at moderate temperature so they don't agglomerate.
- **Add the water-soluble peptides cool and late** in the cool-down train, below 40 °C — the neurotransmitter peptides, the copper carrier, any water-soluble matrikine.
- **Add the copper carrier into a chelator-free phase** specifically, after confirming no high-ascorbate or cationic co-active shares it.
- **Confirm the preservation system holds the whole product** — cosmetic peptides do not self-preserve, and a microbial failure compromises the entire active stack, not just one peptide.
Watch the total peptide load
A three-arm serum stacks three actives' worth of cost, and several cosmetic peptides become a meaningful share of finished-product COGS once their individual loadings climb. The use level for each arm should be set against the claim and the retail price point together, verified in your own base rather than maxed for its own sake — the rate-limiting step for a topical peptide is partitioning across the stratum corneum, not how much you load. Our emulsion-stability guide and layering guide cover how the stack behaves over shelf life and alongside non-peptide actives.
Claim language that stays safe
A multi-peptide serum multiplies the claim-safety surface, so discipline matters: each arm's mechanism stays at the studied/proposed level, the overall claim stays at the appearance level ("supports the appearance of firmness, smoothness, and renewed-looking skin"), no efficacy percentages, no medical or injectable-style language, and every claim reduces to a specific INCI molecule in the formula. A coherent stack is easier to substantiate than a vague one precisely because each arm maps to a named, documented active.
Talk to our regulatory team
Designing a multi-peptide serum?
Tell us the claim arms you need — firmness, expression lines, repair, brightening — and your base chemistry. Pepoderma will send INCI documentation, the chelator-free carrier notes, order-of-addition guidance, and samples for the actives that fit each lane.
Frequently asked questions
- Can you put multiple peptides in one serum?
- Yes — the key is to combine across mechanistic lanes rather than within one. A coherent multi-peptide serum carries a signal peptide (a matrikine such as Matrixyl, studied as a proposed collagen/matrix signal), a neurotransmitter peptide (Argireline, SNAP-8, or SYN-AKE, studied around the appearance of expression lines), and a carrier peptide (GHK-Cu, studied around copper-delivered repair). Because the lanes act through different proposed mechanisms, they combine rather than compete. Three peptides from the same family, by contrast, is just one claim arm tripled.
- What is the main incompatibility when combining peptides?
- If the serum contains GHK-Cu (Copper Tripeptide-1), the copper coordination governs the whole build. The carrier must stay chelator-free (no EDTA, which strips the copper off the peptide), copper-clean, away from cationic bases, and clear of high-load reductive antioxidants like ascorbate or sulfite preservatives in the same phase. That single requirement constrains the preservative system and the other actives more than anything else. If the formula has to live in a copper-hostile base, swap GHK-Cu for the free peptide GHK, which drops the coordination constraints.
- What order should peptides be added to a formula?
- Build the water phase on copper-clean process water with a buffer holding the shared pH window (target 5.5–6.5). Pre-disperse any lipidated actives (the Matrixyl-family matrikines) in a small polysorbate or polyglyceryl co-solvent slurry at moderate temperature. Add the water-soluble peptides cool and late in the cool-down below 40 °C, and add the copper carrier specifically into a chelator-free phase after confirming no high-ascorbate or cationic co-active shares it. Finally, confirm the preservation system holds the whole product, since cosmetic peptides do not self-preserve.
- Does stacking several peptides raise the cost of a serum?
- Yes. A three-arm serum stacks three actives' worth of cost, and several cosmetic peptides become a meaningful share of finished-product COGS once their loadings climb. The use level for each arm should be set against the claim and the retail price point together, verified in your own base rather than maxed for its own sake — the rate-limiting step for a topical peptide is partitioning across the stratum corneum, not the amount loaded. Setting the percentage and the claim together before scaling avoids a post-launch surprise.